ACCREA Marks 50 Successful Surgeries with the AVROS P System

March 23, 2026

A major achievement in robotic-assisted medicine has been reached as ACCREA Medical Robotics marks the completion of 50 successful surgeries using its AVROS P system. Celebrated during a special event at the company's headquarters on Monday, the milestone reflects not just a number, but a meaningful step forward in advancing precision surgery and improving patient care.

The event brought together local authorities, clinical leaders, and trusted partners who have contributed to the company's journey. It was an opportunity to reflect on how a bold concept introduced in 2012 has evolved into a clinically proven solution by 2026—one that is already making a tangible difference in operating rooms.

At its core, Accrea's mission is to empower surgeons through high-precision robotic technology. The AVROS P platform exemplifies how innovation can enhance clinical performance, supporting safer procedures and delivering more predictable outcomes. Each surgery performed to date reinforces confidence in the system's capabilities and its role in modern healthcare.

The milestone also shines a spotlight on Lublin's growing position in the global MedTech landscape. Accrea's success demonstrates that cutting-edge medical technologies can be developed locally while meeting international standards. "Made in Lublin" is increasingly synonymous with quality, ambition, and technological excellence.

With more than 50 procedures successfully completed, Accrea is now looking ahead to international expansion. The company is actively exploring opportunities in the Balkans, Turkey, and Africa, aiming to extend the benefits of robotic-assisted surgery to new healthcare markets and patient populations.

While the first 50 surgeries represent a significant accomplishment, they also mark the beginning of a much larger journey. As demand for precision and innovation in surgery continues to grow, Accrea is poised to play a key role in shaping the future of robotic healthcare.